Catalyst
Slingshot members are tracking this event:
Antares (ATRS) Files NDA with FDA for QuickShot Testosterone Subcutaneous Device
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATRS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 21, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
New Drug Application, Fda, Quickshot Testosterone, Subcutaneous, Device
